Pharmaceutical validation documentation is held to GMP expectations that generic document tools were never built for. Valiqa generates audit-ready IQ, OQ, PQ, PPQ, and CSV protocols, Validation Master Plans, and PFMEAs, maps them to 21 CFR 210/211, EU Annex 15, and international frameworks, and applies Part 11 electronic signatures and a tamper-evident audit trail to the records. Self-serve, transparent pricing, first protocol in minutes.
No credit card required. Plans start at $149 per month.
Pharmaceutical manufacturing sits under current Good Manufacturing Practice, and validation is how you prove your equipment and processes reliably do what they are supposed to. The documentation is judged against a specific and overlapping set of expectations. Here is what shapes it.
US pharmaceutical manufacturing runs under current Good Manufacturing Practice. 21 CFR Part 210 sets the general cGMP framework and Part 211 sets the finished-pharmaceutical requirements, including equipment qualification, process controls, and the documentation that proves a process does what it is supposed to do. Validation records are a routine focus in FDA inspections.
The FDA lifecycle model splits process validation into three stages: Stage 1 Process Design, Stage 2 Process Qualification (which includes Process Performance Qualification, PPQ), and Stage 3 Continued Process Verification. Documentation has to trace design intent through qualification and into ongoing monitoring, not just capture a one-time qualification run.
For product intended for the EU market, Annex 15 sets expectations for qualification and validation activities, including the Validation Master Plan, DQ/IQ/OQ/PQ stages, and change control. Teams that ship to both the US and EU need documentation that satisfies both frameworks without maintaining two disconnected sets of records.
Shared equipment in multi-product facilities has to demonstrate that cleaning procedures reduce residues, cleaning agents, and bioburden below scientifically justified limits. Cleaning validation protocols carry their own acceptance criteria, sampling approach (swab and rinse), and analytical method expectations, and they are a recurring inspection topic.
Computerized systems that manage GMP data, from a chromatography data system to a manufacturing execution system, fall under CSV expectations and 21 CFR Part 11 for electronic records and electronic signatures. FDA's Computer Software Assurance (CSA) guidance encourages a risk-based, critical-thinking approach that concentrates effort where patient and product risk is highest.
A protocol has to arrive with the right sections already in place: purpose, scope, responsibilities, prerequisites, test steps with acceptance criteria, deviation handling, and an approval block. Pharma teams do not have time to reverse-engineer structure from a generic word processor.
Auditors follow the thread from a user or design requirement through the test that verifies it to the recorded result. Validation software should build that traceability in rather than leaving it to a manually maintained spreadsheet.
Electronic records that support GMP decisions need electronic signatures, a tamper-evident audit trail, and controlled versioning. These are properties of the system that holds the record, not something a document generator alone can promise.
Every test and control should map back to the clause it satisfies, whether that is a 21 CFR 211 subpart, an Annex 15 expectation, or an internal SOP. Mapping makes review faster and makes gaps visible before an inspector finds them.
The bottleneck in most validation programs is authoring, not signing. Teams need to move from equipment specification to a defensible first draft quickly, then spend their expert time reviewing and adapting rather than typing boilerplate.
Generate Installation Qualification, Operational Qualification, Performance Qualification, and Process Performance Qualification protocols with test steps, acceptance criteria, and prerequisites drawn from your equipment and process context. DQ (Design Qualification) is supported for the front of the lifecycle.
Author process validation documentation aligned to the Stage 1 to Stage 3 model, so design intent, qualification, and continued verification connect rather than living as isolated files.
Produce a VMP that lists systems in scope, the validation approach, responsibilities, and the schedule, giving inspectors and internal reviewers the single map they expect to see first.
Build Process Failure Mode and Effects Analysis entries so protocol scope and test rigor are justified by risk, in the spirit of ICH Q9 quality risk management and FDA's CSA critical-thinking approach.
Map protocols to GMP expectations and international frameworks. Beyond US cGMP, Valiqa supports standards coverage spanning the UK, EU, India, Korea, Mexico, and Brazil, so teams shipping to multiple markets can keep one coherent record set.
Upload equipment specifications and supporting documents so generated content reflects your actual make, model, ranges, and utilities rather than generic placeholders. The draft starts closer to defensible, which shortens review.
Approvals are captured with electronic signatures and a hash-chained, tamper-evident audit trail, with protocol versioning throughout. These controls support 21 CFR Part 11 expectations for electronic records and signatures on GMP documentation.
Not sure which protocol type you need first? Try the protocol selector or run the validation software evaluator to score your current approach.
Mid-market pharmaceutical manufacturers, roughly 10 to 500 employees, that need audit-ready validation without a six-figure implementation or an enterprise sales cycle.
Contract Development and Manufacturing Organizations (CDMOs) that stand up validation packages for many clients and equipment types and need to move quickly without sacrificing rigor.
Teams that want to self-serve: sign up, upload equipment specifications, and produce a defensible first protocol the same day.
Programs shipping to multiple markets that want US cGMP plus international framework mapping in one place.
Valiqa is a self-serve platform, not a consulting engagement. If your program needs on-site validation engineers to author and execute protocols for you, a services firm is a better fit and Valiqa can complement that work.
Valiqa generates and manages validation documentation and applies Part 11 controls to those records. It is not a full enterprise QMS, LIMS, or MES, and it does not replace your quality system of record for every GMP process.
Regulatory frameworks describe expectations, not guarantees. Valiqa accelerates authoring and mapping, but your quality unit remains accountable for reviewing, approving, and defending every document. No software makes a protocol audit-proof on its own.
If you require fully guided execution with enforced e-signature workflows for every step across a large multi-site enterprise today, evaluate the fit carefully against your process before committing.
Weighing Valiqa against enterprise validation platforms or point tools? See the side-by-side comparisons.
Sign up, upload your equipment specifications, and produce an audit-ready draft in minutes. 14-day free trial, no credit card, transparent pricing from $149 per month.
We use essential cookies for authentication and security. With your consent, we also use Microsoft Clarity on our marketing pages to understand how visitors navigate the site. Learn more.